JBCHEPHARMNSEJB Chemicals & Pharmaceuticals Limited· PharmaceuticalsMediumNeutral
Announced Wed, 6 Aug · 20:01 IST

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Change in Auditors of the company.

Management Changes View source PDF

JBCHEPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

JB Chemicals & Pharmaceuticals has re-appointed Deloitte Haskins & Sells LLP as its Statutory Auditors at the Annual General Meeting held on August 6, 2025. Deloitte will continue to serve in this role until the conclusion of the company's 54th Annual General Meeting. Deloitte Haskins & Sells LLP is registered with the ICAI (FRN: 117366W/W-100018) and has offices across multiple Indian cities including Mumbai, Gurugram, Bangalore, Chennai, and others. This is a continuation of the existing auditor relationship rather than a change in auditors, as suggested by the headline.

Likely market impact

This is a routine corporate governance disclosure with no material impact on shareholders. Continuity with a Big Four audit firm like Deloitte reinforces confidence in the company's financial reporting and audit quality.